dc.contributor.author | Alabi, Christopher A. | |
dc.contributor.author | Sahay, Gaurav | |
dc.contributor.author | Yin, Hao | |
dc.contributor.author | Luly, Kathryn M. | |
dc.contributor.author | Anderson, Daniel Griffith | |
dc.contributor.author | Love, Kevin T | |
dc.contributor.author | Langer, Robert S | |
dc.date.accessioned | 2014-08-29T11:50:53Z | |
dc.date.available | 2014-08-29T11:50:53Z | |
dc.date.issued | 2013-08 | |
dc.date.submitted | 2013-04 | |
dc.identifier.issn | 0027-8424 | |
dc.identifier.issn | 1091-6490 | |
dc.identifier.uri | http://hdl.handle.net/1721.1/89097 | |
dc.description.abstract | Nanoparticle-mediated siRNA delivery is a complex process that requires transport across numerous extracellular and intracellular barriers. As such, the development of nanoparticles for efficient delivery would benefit from an understanding of how parameters associated with these barriers relate to the physicochemical properties of nanoparticles. Here, we use a multiparametric approach for the evaluation of lipid nanoparticles (LNPs) to identify relationships between structure, biological function, and biological activity. Our results indicate that evaluation of multiple parameters associated with barriers to delivery such as siRNA entrapment, pK[subscript a], LNP stability, and cell uptake as a collective may serve as a useful prescreening tool for the advancement of LNPs in vivo. This multiparametric approach complements the use of in vitro efficacy results alone for prescreening and improves in vitro–in vivo translation by minimizing false negatives. For the LNPs used in this work, the evaluation of multiple parameters enabled the identification of LNP pK[subscript a] as one of the key determinants of LNP function and activity both in vitro and in vivo. It is anticipated that this type of analysis can aid in the identification of meaningful structure–function–activity relationships, improve the in vitro screening process of nanoparticles before in vivo use, and facilitate the future design of potent nanocarriers. | en_US |
dc.description.sponsorship | National Institutes of Health (U.S.) (Grant R37-EB000244) | en_US |
dc.description.sponsorship | Alnylam Pharmaceuticals (Firm) | en_US |
dc.description.sponsorship | National Institutes of Health (U.S.) (Postdoctoral Fellowship) | en_US |
dc.language.iso | en_US | |
dc.publisher | National Academy of Sciences (U.S.) | en_US |
dc.relation.isversionof | http://dx.doi.org/10.1073/pnas.1306529110 | en_US |
dc.rights | Article is made available in accordance with the publisher's policy and may be subject to US copyright law. Please refer to the publisher's site for terms of use. | en_US |
dc.source | PNAS | en_US |
dc.title | Multiparametric approach for the evaluation of lipid nanoparticles for siRNA delivery | en_US |
dc.type | Article | en_US |
dc.identifier.citation | Alabi, C. A., K. T. Love, G. Sahay, H. Yin, K. M. Luly, R. Langer, and D. G. Anderson. “Multiparametric Approach for the Evaluation of Lipid Nanoparticles for siRNA Delivery.” Proceedings of the National Academy of Sciences 110, no. 32 (July 23, 2013): 12881–12886. | en_US |
dc.contributor.department | Massachusetts Institute of Technology. Institute for Medical Engineering & Science | en_US |
dc.contributor.department | Harvard University--MIT Division of Health Sciences and Technology | en_US |
dc.contributor.department | Massachusetts Institute of Technology. Department of Chemical Engineering | en_US |
dc.contributor.department | Koch Institute for Integrative Cancer Research at MIT | en_US |
dc.contributor.mitauthor | Alabi, Christopher A. | en_US |
dc.contributor.mitauthor | Love, Kevin T. | en_US |
dc.contributor.mitauthor | Sahay, Gaurav | en_US |
dc.contributor.mitauthor | Yin, Hao | en_US |
dc.contributor.mitauthor | Langer, Robert | en_US |
dc.contributor.mitauthor | Anderson, Daniel Griffith | en_US |
dc.relation.journal | Proceedings of the National Academy of Sciences | en_US |
dc.eprint.version | Final published version | en_US |
dc.type.uri | http://purl.org/eprint/type/JournalArticle | en_US |
eprint.status | http://purl.org/eprint/status/PeerReviewed | en_US |
dspace.orderedauthors | Alabi, C. A.; Love, K. T.; Sahay, G.; Yin, H.; Luly, K. M.; Langer, R.; Anderson, D. G. | en_US |
dc.identifier.orcid | https://orcid.org/0000-0002-2100-1171 | |
dc.identifier.orcid | https://orcid.org/0000-0001-5629-4798 | |
dc.identifier.orcid | https://orcid.org/0000-0001-6898-3793 | |
dc.identifier.orcid | https://orcid.org/0000-0003-4255-0492 | |
mit.license | PUBLISHER_POLICY | en_US |
mit.metadata.status | Complete | |